UAB partners with state agencies and organizations to aggressively decrease the spread of HIV/AIDS to the point of elimination of the spread of AIDS by 2030.
Small molecule inhibitor prevents or impedes tooth cavities in a preclinical model
Written by Jeff Hansen
The inhibitor blocks Streptococcus mutans from sticking on the tooth surface. About 2.3 billion people worldwide have tooth decay in their permanent teeth, primarily caused by this bacteria.
Thomas Buford, Ph.D. joins the UAB School of Medicine’s Division of Gerontology, Geriatrics & Palliative Care and associate director of the UAB Center for Exercise Medicine.
Lipstein to deliver 2017 keynote for Leadership in Academic Medicine Lecture series
Written by Katelyn Howard
Steven H. Lipstein, chief executive officer of BJC HealthCare will present “The Future of Academic Medicine: Rosy or Rocky?” as the keynote speaker for the 2017 Leadership in Academic Medicine Lecture series, sponsored by UAB Medicine.
HudsonAlpha and UAB awarded $10 million for newborn whole genome sequencing project
Written by Bob Shepard
UAB, Alabama’s leader in precision medicine, joins with Huntsville’s HudsonAlpha in CSER2, an NIH project to bring genomic medicine to more children with birth defects or genetic disorders.
The August issue of the journal focused on genomics in rheumatic diseases, the complex effort to understand the genetic underpinnings of more than 100 diseases that affect joints and muscles.
UAB Hospital continues to be highly ranked by U.S. News and World Report, and is noted as the No. 1 hospital in Alabama.
UAB’s long-running study of cannabidiol reveals potential interactions between CBD and some commonly used anti-epileptic drugs.